Apimeds Pharmaceuticals US
$3.01
9
-$0.20-6.23%Friday 20:00
-$0.15-4.98%Friday 23:55After hours
Statistics
Day High
2.94
Day Low
2.94
52W High
38.95
52W Low
1.6
Volume
102
Avg. Volume
-
Mkt Cap
4.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-6MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow APUS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Show More
CEO
Vinod Menon
Employees
7
Country
United States
ISIN
US03771D2018
Listings
0 Comments
Share your thoughts
FAQs
What is Apimeds Pharmaceuticals US stock price today?▼
The current price of APUS is $3.01 USD — it has decreased by -6.23% in the past 24 hours. Watch Apimeds Pharmaceuticals US stock price performance more closely on the chart.
What is Apimeds Pharmaceuticals US stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Apimeds Pharmaceuticals US stocks are traded under the ticker APUS.
Is Apimeds Pharmaceuticals US stock price growing?▼
APUS stock has risen by +4.15% compared to the previous week, the month change is a -26.59% fall, over the last year Apimeds Pharmaceuticals US has showed a -86.26% decrease.
What is Apimeds Pharmaceuticals US market cap?▼
Today Apimeds Pharmaceuticals US has the market capitalization of 4.54M
What is Apimeds Pharmaceuticals US revenue for the last year?▼
Apimeds Pharmaceuticals US revenue for the last year amounts to 0 USD.
What is Apimeds Pharmaceuticals US net income for the last year?▼
APUS net income for the last year is -6M USD.
How many employees does Apimeds Pharmaceuticals US have?▼
As of November 1, 2026, the company has 7 employees.
In which sector is Apimeds Pharmaceuticals US located?▼
Apimeds Pharmaceuticals US operates in the Health & Wellness sector.
When did Apimeds Pharmaceuticals US complete a stock split?▼
The last stock split for Apimeds Pharmaceuticals US was on July 24, 2026 with a ratio of 1:10.
Where is Apimeds Pharmaceuticals US headquartered?▼
Apimeds Pharmaceuticals US is headquartered in MATAWAN, United States.